Loading clinical trials...
Loading clinical trials...
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Conditions
Interventions
Lenvatinib
Locations
78
United States
Phoenix, Arizona, United States
Scottsdale, Arizona, United States
Tucson, Arizona, United States
Los Angeles, California, United States
Honolulu, Hawaii, United States
Arlington Heights, Illinois, United States
Start Date
March 1, 2010
Primary Completion Date
May 1, 2012
Completion Date
October 1, 2015
Last Updated
June 22, 2023
NCT06340568
NCT06952504
NCT06257264
NCT06253494
NCT06547840
NCT05990426
Lead Sponsor
Eisai Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions